UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

1. Díaz-Santa, J.
2. Rodríguez-Romanos, R.
3. Osca, G.
4. Pratcorona, M.
5. Garrido, A.
6. Coll, R.
7. Moret, C.
8. Escoda, L.
9. Tormo, M.
10. Heras, I.
11. Arnan, M.
12. Vives, S.
13. Salamero, O.
14. Lloveras, N.
15. Bargay, J.
16. Sampol, A.
17. Cruz, D.
18. Garcia, A.
19. Quiñones, T.
20. Esteve, J.
21. Sierra, J.
22. Gallardo, D.